The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome
Open accessAbstract
T cell-mediated hyperinflammatory responses, such as cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS), are now well-established toxicities of chimeric antigen receptor (CAR) T cell therapy. As the field of CAR T cells advances, however, there is increasing recognition that hemophagocytic lymphohistiocytosis (HLH)-like toxicities following CAR T cell infusion are occurring broadly across patient populations and CAR T cell constructs. Importantly, these HLH-like toxicities are often not as directly associated with CRS and/or its severity as initially described. This emergent toxicity, however ill-defined, is associated with life-threatening complications, creating an urgent need for improved identification and optimal management. With the goal of improving patient outcomes and formulating a framework to characterize and study this HLH-like syndrome, we established an American Society for Transplantation and Cellular Therapy panel composed of experts in primary and secondary HLH, pediatric and adult HLH, infectious disease, rheumatology and hematology, oncology, and cellular therapy. Through this effort, we provide an overview of the underlying biology of classical primary and secondary HLH, explore its relationship with similar manifestations following CAR T cell infusions, and propose the term "immune effector cell-associated HLH-like syndrome (IEC-HS)" to describe this emergent toxicity. We also delineate a framework for identifying IEC-HS and put forward a grading schema that can be used to assess severity and facilitate cross-trial comparisons. Additionally, given the critical need to optimize outcomes for patients experiencing IEC-HS, we provide insight into potential treatment approaches and strategies to optimize supportive care and delineate alternate etiologies that should be considered in a patient presenting with IEC-HS. By collectively defining IEC-HS as a hyperinflammatory toxicity, we can now embark on further study of the pathophysiology underlying this toxicity profile and make strides toward a more comprehensive assessment and treatment approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
COVID-19: consider cytokine storm syndromes and immunosuppression
Mehta, P., McAuley, D. F., Brown, M., Sanchez, E., Tattersall, R. S., & Manson, J. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30628-0 · Cited by 9,664
Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia
Maude, S. L., Laetsch, T. W., Buechner, J., Rives, S., Boyer, M., Bittencourt, H., Bader, P., Verneris, M. R., Stefanski, H. E., Myers, G. D., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1709866 · Cited by 5,735
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Maude, S. L., Frey, N., Shaw, P. A., Aplenc, R., Barrett, D. M., Bunin, N. J., Chew, A., Gonzalez, V. E., Zheng, Z., Lacey, S. F., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407222 · Cited by 5,413
Self-citationHLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis
Henter, J., Horne, A., Aricó, M., Egeler, R. M., Filipovich, A. H., Imashuku, S., Ladisch, S., McClain, K., Webb, D., Winiarski, J., et al. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.21039 · Cited by 5,386
Self-citationLee, D. W., Santomasso, B. D., Locke, F. L., Ghobadi, A., Turtle, C. J., Brudno, J. N., Maus, M. V., Park, J. H., Mead, E., Pavletic, S., et al. (2019) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2018.12.758 · Cited by 3,675
Self-citationChimeric antigen receptor–modified T cells in chronic lymphoid leukemia
Porter, D. L., Levine, B. L., Kalos, M., Bagg, A., & June, C. H. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103849 · Cited by 3,565
Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia
Grupp, S. A., Kalos, M., Barrett, D., Aplenc, R., Porter, D. L., Rheingold, S. R., Teachey, D. T., Chew, A., Hauck, B., Wright, J. F., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215134 · Cited by 3,509
Self-citationHematological Problems in Pediatric Intensive Care
Revel-Vilk, S., Cox, P., Robitaille, N., & Blanchette, V. (2014) · Pediatric and Adolescent Medicine · doi:10.1159/000350346 · Cited by 3,508
Current concepts in the diagnosis and management of cytokine release syndrome.
Lee, D. W., Gardner, R., Porter, D. L., Louis, C. U., Ahmed, N., Jensen, M., Grupp, S. A., & Mackall, C. L. (2014) · Blood · doi:10.1182/blood-2014-05-552729 · Cited by 2,806
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Davila, M. L., Riviere, I., Wang, X., Bartido, S., Park, J., Curran, K., Chung, S. S., Stefanski, J., Borquez-Ojeda, O., Olszewska, M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3008226 · Cited by 2,476
Chimeric antigen receptor T-cell therapy—assessment and management of toxicities
Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W., Gutierrez, C., Locke, F. L., Komanduri, K. V., Lin, Y., Jain, N., Daver, N., et al. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2017.148 · Cited by 2,438
Self-citationCD19 CAR–T cells of defined CD4+:CD8+ composition in adult B cell ALL patients
Turtle, C. J., Hanafi, L.-A., Berger, C., Gooley, T. A., Cherian, S., Hudecek, M., Sommermeyer, D., Melville, K., Pender, B., Budiarto, T. M., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci85309 · Cited by 2,112
Tomblyn, M., Chiller, T., Einsele, H., Gress, R., Sepkowitz, K., Storek, J., Wingard, J. R., Young, J.-A. H., & Boeckh, M. A. (2009) · Biology of Blood and Marrow Transplantation · doi:10.1016/j.bbmt.2009.06.019 · Cited by 1,797
Porter, D. L., Hwang, W.-T., Frey, N. V., Lacey, S. F., Shaw, P. A., Loren, A. W., Bagg, A., Marcucci, K. T., Shen, A., Gonzalez, V., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac5415 · Cited by 1,729
Self-citationThe Basic Principles of Chimeric Antigen Receptor Design
Sadelain, M., Brentjens, R., & Rivière, I. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0548 · Cited by 1,535
Fardet, L., Galicier, L., Lambotte, O., Marzac, C., Aumont, C., Chahwan, D., Coppo, P., & Hejblum, G. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38690 · Cited by 1,475
Kochenderfer, J. N., Dudley, M. E., Feldman, S. A., Wilson, W. H., Spaner, D. E., Maric, I., Stetler-Stevenson, M., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2012) · Blood · doi:10.1182/blood-2011-10-384388 · Cited by 1,440
Perforin Gene Defects in Familial Hemophagocytic Lymphohistiocytosis
Stepp, S. E., Dufourcq-Lagelouse, R., Deist, F. L., Bhawan, S., Certain, S., Mathew, P. A., Henter, J.-I., Bennett, M., Fischer, A., Basile, G. D. S., et al. (1999) · Science · doi:10.1126/science.286.5446.1957 · Cited by 1,241
Self-citationHow I treat hemophagocytic lymphohistiocytosis
Jordan, M. B., Allen, C. E., Weitzman, S., Filipovich, A. H., & McClain, K. L. (2011) · Blood · doi:10.1182/blood-2011-03-278127 · Cited by 1,148
Recommendations for the management of hemophagocytic lymphohistiocytosis in adults
La Rosée, P., Horne, A., Hines, M., von Bahr Greenwood, T., Machowicz, R., Berliner, N., Birndt, S., Gil-Herrera, J., Girschikofsky, M., Jordan, M. B., et al. (2019) · Blood · doi:10.1182/blood.2018894618 · Cited by 1,108
Self-citationCytokine release syndrome and associated neurotoxicity in cancer immunotherapy
Morris, E. C., Neelapu, S. S., Giavridis, T., & Sadelain, M. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00547-6 · Cited by 1,104
Self-citationTeachey, D. T., Lacey, S. F., Shaw, P. A., Melenhorst, J. J., Maude, S. L., Frey, N., Pequignot, E., Gonzalez, V. E., Chen, F., Finklestein, J., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-0040 · Cited by 1,102
Self-citationTransfusion Strategies for Patients in Pediatric Intensive Care Units
Lacroix, J., Hébert, P. C., Hutchison, J. S., Hume, H. A., Tucci, M., Ducruet, T., Gauvin, F., Collet, J.-P., Toledano, B. J., Robillard, P., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066240 · Cited by 1,085
Sayos, J., Wu, C., Morra, M., Wang, N., Zhang, X., Allen, D., van Schaik, S., Notarangelo, L., Geha, R., Roncarolo, M. G., et al. (1998) · Nature · doi:10.1038/26683 · Cited by 943
Henter, J.-I. (2002) · Blood · doi:10.1182/blood-2002-01-0172 · Cited by 900
Self-citationLe, R. Q., Li, L., Yuan, W., Shord, S. S., Nie, L., Habtemariam, B. A., Przepiorka, D., Farrell, A. T., & Pazdur, R. (2018) · The Oncologist · doi:10.1634/theoncologist.2018-0028 · Cited by 873
Coffey, A. J., Brooksbank, R. A., Brandau, O., Oohashi, T., Howell, G. R., Bye, J. M., Cahn, A. P., Durham, J., Heath, P., Wray, P., et al. (1998) · Nature Genetics · doi:10.1038/2424 · Cited by 754
Canna, S. W., de Jesus, A. A., Gouni, S., Brooks, S. R., Marrero, B., Liu, Y., DiMattia, M. A., Zaal, K. J. M., Sanchez, G. A. M., Kim, H., et al. (2014) · Nature Genetics · doi:10.1038/ng.3089 · Cited by 740
Acute Myeloid Leukemia in Children Treated with Epipodophyllotoxins for Acute Lymphoblastic Leukemia
Pui, C.-H., Ribeiro, R. C., Hancock, M. L., Rivera, G. K., Evans, W. E., Raimondi, S. C., Head, D. R., Behm, F. G., Mahmoud, M. H., Sandlund, J. T., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199112123252402 · Cited by 713
Trottestam, H., Horne, A., Aricò, M., Egeler, R. M., Filipovich, A. H., Gadner, H., Imashuku, S., Ladisch, S., Webb, D., Janka, G., et al. (2011) · Blood · doi:10.1182/blood-2011-06-356261 · Cited by 685
Self-citationBergsten, E., Horne, A., Aricó, M., Astigarraga, I., Egeler, R. M., Filipovich, A. H., Ishii, E., Janka, G., Ladisch, S., Lehmberg, K., et al. (2017) · Blood · doi:10.1182/blood-2017-06-788349 · Cited by 677
Self-citationTeachey, D. T., Rheingold, S. R., Maude, S. L., Zugmaier, G., Barrett, D. M., Seif, A. E., Nichols, K. E., Suppa, E. K., Kalos, M., Berg, R. A., et al. (2013) · Blood · doi:10.1182/blood-2013-02-485623 · Cited by 613
Self-citationInfections associated with haemophagocytic syndrome
Rouphael, N. G., Talati, N. J., Vaughan, C., Cunningham, K., Moreira, R., & Gould, C. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70290-6 · Cited by 596
Identification of the homologous beige and Chediak–Higashi syndrome genes
Barbosa, M. D. F. S., Nguyen, Q. A., Tchernev, V. T., Ashley, J. A., Detter, J. C., Blaydes, S. M., Brandt, S. J., Chotai, D., Hodgman, C., Solari, R. C. E., et al. (1996) · Nature · doi:10.1038/382262a0 · Cited by 552
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis
Locatelli, F., Jordan, M. B., Allen, C., Cesaro, S., Rizzari, C., Rao, A., Degar, B., Garrington, T. P., Sevilla, J., Putti, M.-C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1911326 · Cited by 534
The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells
Mestermann, K., Giavridis, T., Weber, J., Rydzek, J., Frenz, S., Nerreter, T., Mades, A., Sadelain, M., Einsele, H., & Hudecek, M. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau5907 · Cited by 531
Hypercytokinemia in familial hemophagocytic lymphohistiocytosis
Henter, J., Elinder, G., Soder, O., Hansson, M., Andersson, B., & Andersson, U. (1991) · Blood · doi:10.1182/blood.v78.11.2918.2918 · Cited by 505
Self-citationInactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome
Nichols, K. E., Harkin, D. P., Levitz, S., Krainer, M., Kolquist, K. A., Genovese, C., Bernard, A., Ferguson, M., Zuo, L., Snyder, E., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13765 · Cited by 498
Pediatric hemophagocytic lymphohistiocytosis
Canna, S. W., & Marsh, R. A. (2020) · Blood · doi:10.1182/blood.2019000936 · Cited by 496
Self-citationFitzgerald, J. C., Weiss, S. L., Maude, S. L., Barrett, D. M., Lacey, S. F., Melenhorst, J. J., Shaw, P., Berg, R. A., June, C. H., Porter, D. L., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002053 · Cited by 459
Self-citationMacrophage activation syndrome in the era of biologic therapy
Grom, A. A., Horne, A., & De Benedetti, F. (2016) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.179 · Cited by 448
Jordan, M. B., Allen, C. E., Greenberg, J., Henry, M., Hermiston, M. L., Kumar, A., Hines, M., Eckstein, O., Ladisch, S., Nichols, K. E., et al. (2019) · Pediatric Blood & Cancer · doi:10.1002/pbc.27929 · Cited by 424
Self-citationShah, N. N., Highfill, S. L., Shalabi, H., Yates, B., Jin, J., Wolters, P. L., Ombrello, A., Steinberg, S. M., Martin, S., Delbrook, C., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.03279 · Cited by 421
Self-citationHow I treat hemophagocytic lymphohistiocytosis in the adult patient
Schram, A. M., & Berliner, N. (2015) · Blood · doi:10.1182/blood-2015-01-551622 · Cited by 414
Self-citationGrading of cytokine release syndrome associated with the CAR T cell therapy tisagenlecleucel
Porter, D., Frey, N., Wood, P. A., Weng, Y., & Grupp, S. A. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0571-y · Cited by 401
Self-citationKochenderfer, J. N., Yu, Z., Frasheri, D., Restifo, N. P., & Rosenberg, S. A. (2010) · Blood · doi:10.1182/blood-2010-01-265041 · Cited by 391
CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours
Larson, R. C., Kann, M. C., Bailey, S. R., Haradhvala, N. J., Llopis, P. M., Bouffard, A. A., Scarfó, I., Leick, M. B., Grauwet, K., Berger, T. R., et al. (2022) · Nature · doi:10.1038/s41586-022-04585-5 · Cited by 352
Self-citationHayden, A., Park, S., Giustini, D., Lee, A. Y. Y., & Chen, L. Y. C. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.05.001 · Cited by 338
Reactive Hemophagocytic Syndrome in Adults: A Retrospective Analysis of 162 Patients
Rivière, S., Galicier, L., Coppo, P., Marzac, C., Aumont, C., Lambotte, O., & Fardet, L. (2014) · The American Journal of Medicine · doi:10.1016/j.amjmed.2014.04.034 · Cited by 324
Prognostic Factors and Outcomes of Adults With Hemophagocytic Lymphohistiocytosis
Parikh, S. A., Kapoor, P., Letendre, L., Kumar, S., & Wolanskyj, A. P. (2014) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.12.012 · Cited by 323
Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab
Marsh, R. A., Allen, C. E., McClain, K. L., Weinstein, J. L., Kanter, J., Skiles, J., Lee, N. D., Khan, S. P., Lawrence, J., Mo, J. Q., et al. (2013) · Pediatric Blood & Cancer · doi:10.1002/pbc.24188 · Cited by 310
Self-citationSafety of extended treatment with anakinra in patients with rheumatoid arthritis
Fleischmann, R. M., Tesser, J., Schiff, M. H., Schechtman, J., Burmester, G.-R., Bennett, R., Modafferi, D., Zhou, L., Bell, D., & Appleton, B. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2005.048371 · Cited by 305
Hill, J. A., & Seo, S. K. (2020) · Blood · doi:10.1182/blood.2019004000 · Cited by 305
Self-citationBracaglia, C., de Graaf, K., Pires Marafon, D., Guilhot, F., Ferlin, W., Prencipe, G., Caiello, I., Davì, S., Schulert, G., Ravelli, A., et al. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2015-209020 · Cited by 290
Gardner, R. A., Ceppi, F., Rivers, J., Annesley, C., Summers, C., Taraseviciute, A., Gust, J., Leger, K. J., Tarlock, K., Cooper, T. M., et al. (2019) · Blood · doi:10.1182/blood.2019001463 · Cited by 286
Vlaar, A. P., Oczkowski, S., de Bruin, S., Wijnberge, M., Antonelli, M., Aubron, C., Aries, P., Duranteau, J., Juffermans, N. P., Meier, J., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-019-05884-8 · Cited by 284
Mahlaoui, N., Ouachée-Chardin, M., de Saint Basile, G., Neven, B., Picard, C., Blanche, S., & Fischer, A. (2007) · Pediatrics · doi:10.1542/peds.2006-3164 · Cited by 256
Pharmacologic control of CAR-T cell function using dasatinib
Weber, E. W., Lynn, R. C., Sotillo, E., Lattin, J., Xu, P., & Mackall, C. L. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018028720 · Cited by 239
Diagnostic Accuracy of a Specific Cytokine Pattern in Hemophagocytic Lymphohistiocytosis in Children
Xu, X.-J., Tang, Y.-M., Song, H., Yang, S.-L., Xu, W.-Q., Zhao, N., Shi, S.-W., Shen, H.-P., Mao, J.-Q., Zhang, L.-Y., et al. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.11.046 · Cited by 225
Marked hyperferritinemia does not predict for HLH in the adult population
Schram, A. M., Campigotto, F., Mullally, A., Fogerty, A., Massarotti, E., Neuberg, D., & Berliner, N. (2015) · Blood · doi:10.1182/blood-2014-10-602607 · Cited by 222
Self-citationStrati, P., Ahmed, S., Furqan, F., Fayad, L. E., Lee, H. J., Iyer, S. P., Nair, R., Nastoupil, L. J., Parmar, S., Rodriguez, M. A., et al. (2021) · Blood · doi:10.1182/blood.2020008865 · Cited by 218
Self-citationOluwole, O. O., Bouabdallah, K., Muñoz, J., De Guibert, S., Vose, J. M., Bartlett, N. L., Lin, Y., Deol, A., McSweeney, P. A., Goy, A. H., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17527 · Cited by 218
Self-citationMacrophage Activation Syndrome
Ravelli, A., Davì, S., Minoia, F., Martini, A., & Cron, R. Q. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.06.010 · Cited by 212
Arca, M., Fardet, L., Galicier, L., Rivière, S., Marzac, C., Aumont, C., Lambotte, O., & Coppo, P. (2015) · British Journal of Haematology · doi:10.1111/bjh.13102 · Cited by 211
Hemophagocytic Lymphohistiocytosis: Clinical Analysis of 103 Adult Patients
Li, J., Wang, Q., Zheng, W., Ma, J., Zhang, W., Wang, W., & Tian, X. (2014) · Medicine · doi:10.1097/md.0000000000000022 · Cited by 208
Johnson, T. S., Terrell, C. E., Millen, S. H., Katz, J. D., Hildeman, D. A., & Jordan, M. B. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1302282 · Cited by 203
Strati, P., Ahmed, S., Kebriaei, P., Nastoupil, L. J., Claussen, C. M., Watson, G., Horowitz, S. B., Brown, A. R. T., Do, B., Rodriguez, M. A., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002328 · Cited by 201
Self-citationEhl, S., Astigarraga, I., von Bahr Greenwood, T., Hines, M., Horne, A., Ishii, E., Janka, G., Jordan, M. B., La Rosée, P., Lehmberg, K., et al. (2018) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.05.031 · Cited by 200
Self-citationGenetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis
Chinn, I. K., Eckstein, O. S., Peckham-Gregory, E. C., Goldberg, B. R., Forbes, L. R., Nicholas, S. K., Mace, E. M., Vogel, T. P., Abhyankar, H. A., Diaz, M. I., et al. (2018) · Blood · doi:10.1182/blood-2017-11-814244 · Cited by 199
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells
Lichtenstein, D. A., Schischlik, F., Shao, L., Steinberg, S. M., Yates, B., Wang, H.-W., Wang, Y., Inglefield, J., Dulau-Florea, A., Ceppi, F., et al. (2021) · Blood · doi:10.1182/blood.2021011898 · Cited by 196
Self-citationCAR T-Cell Associated Neurotoxicity: Mechanisms, Clinicopathologic Correlates, and Future Directions
Hunter, B. D., & Jacobson, C. A. (2019) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djz017 · Cited by 193
Treatment of juvenile idiopathic arthritis: a revolution in care
Stoll, M. L., & Cron, R. Q. (2014) · Pediatric Rheumatology · doi:10.1186/1546-0096-12-13 · Cited by 176
Sandler, R. D., Tattersall, R. S., Schoemans, H., Greco, R., Badoglio, M., Labopin, M., Alexander, T., Kirgizov, K., Rovira, M., Saif, M., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00524 · Cited by 172
Bailey, S. R., Vatsa, S., Larson, R. C., Bouffard, A. A., Scarfò, I., Kann, M. C., Berger, T. R., Leick, M. B., Wehrli, M., Schmidts, A., et al. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0181 · Cited by 165
Self-citationLiu, S., Deng, B., Yin, Z., Pan, J., Lin, Y., Ling, Z., Wu, T., Chen, D., Chang, A. H., Gao, Z., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0280-y · Cited by 161
Self-citationZoref‐Lorenz, A., Murakami, J., Hofstetter, L., Iyer, S. P., Alotaibi, A. S., Mohamed, S., Miller, P. G., Guber, E., Weinstein, S., Yacobovich, J., et al. (2021) · Blood · doi:10.1182/blood.2021012764 · Cited by 160
Self-citationImashuku, S., Kuriyama, K., Sakai, R., Nakao, Y., Masuda, S., Yasuda, N., Kawano, F., Yakushijin, K., Miyagawa, A., Nakao, T., et al. (2003) · Medical and Pediatric Oncology · doi:10.1002/mpo.10314 · Cited by 149
Hines, M., Greenwood, T. V. B., Beutel, G., Beutel, K., Hays, J. A., Horne, A., Janka, G., Jordan, M. B., van Laar, J. A. M., Lachmann, G., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005361 · Cited by 149
Self-citationToxicity management after chimeric antigen receptor T cell therapy: one size does not fit 'ALL'
Neelapu, S. S., Tummala, S., Kebriaei, P., Wierda, W. G., Locke, F. L., Lin, Y., Jain, N., Daver, N. G., Gulbis, A. M., Adkins, S., et al. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.20 · Cited by 148
Self-citationTopp, M. S., van Meerten, T., Houot, R., Minnema, M. C., Bouabdallah, K. K., Lugtenburg, P. J., Thiéblemont, C., Wermke, M., Song, K., Avivi, I. M., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17673 · Cited by 147
Wehrli, M., Gallagher, K., Chen, Y., Leick, M. B., McAfee, S. L., El-Jawahri, A. R., DeFilipp, Z. M., Horick, N., O’Donnell, P. V., Spitzer, T. R., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003847 · Cited by 147
Self-citationWohlfarth, P., Agis, H., Gualdoni, G. A., Weber, J., Staudinger, T., Schellongowski, P., & Robak, O. (2017) · Journal of Intensive Care Medicine · doi:10.1177/0885066617711386 · Cited by 142
Hakki, M., Aitken, S. L., Danziger‐Isakov, L. A., Michaels, M. G., Carpenter, P. A., Chemaly, R. F., Papanicolaou, G. A., Boeckh, M., & Marty, F. M. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.05.001 · Cited by 138
Hemophagocytic syndrome: primary forms and predisposing conditions
Sepulveda, F. E., & Basile, G. D. S. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.08.004 · Cited by 133
Hemophagocytic lymphohistiocytosis‐like toxicity (carHLH) after CD19‐specific CAR T‐cell therapy
Hines, M., Keenan, C., Marón, G. M., Cheng, C., Zhou, Y., Sharma, A., Hurley, C., Nichols, K. E., Gottschalk, S. M., Triplett, B. M., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17662 · Cited by 132
Self-citationMalignancy-associated haemophagocytic lymphohistiocytosis
Setiadi, A., Zoref-Lorenz, A., Lee, C. Y., Jordan, M. B., & Chen, L. Y. C. (2022) · The Lancet Haematology · doi:10.1016/s2352-3026(21)00366-5 · Cited by 128
Kogawa, K., Sato, H., Asano, T., Ohga, S., Kudo, K., Morimoto, A., Ohta, S., Wakiguchi, H., Kanegane, H., Oda, M., et al. (2014) · Pediatric Blood & Cancer · doi:10.1002/pbc.24980 · Cited by 100
Faramand, R. G., Jain, M. D., Staedtke, V., Kotani, H., Bai, R.-Y., Reid, K. M., Lee, S. B., Spitler, K., Wang, X., Cao, B., et al. (2020) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-1434 · Cited by 92
Self-citationNeuroinflammatory Disease as an Isolated Manifestation of Hemophagocytic Lymphohistiocytosis
Blincoe, A., Heeg, M., Campbell, P. K., Hines, M., Khojah, A. M., Klein‐Gitelman, M., Talano, J., Speckmann, C., Touzot, F., Lankester, A. C., et al. (2020) · Journal of Clinical Immunology · doi:10.1007/s10875-020-00814-6 · Cited by 89
Self-citationPerforin-deficient CAR T cells recapitulate late-onset inflammatory toxicities observed in patients
Ishii, K., Pouzolles, M., Chien, C. D., Erwin-Cohen, R. A., Kohler, M. E., Qin, H., Lei, H., Kuhn, S. A., Ombrello, A. K., Dulau‐Florea, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci130059 · Cited by 82
Self-citationDiorio, C. J., Shraim, R., Myers, R. M., Behrens, E. M., Canna, S., Bassiri, H., Aplenc, R., Burudpakdee, C., Chen, F., DiNofia, A. M., et al. (2022) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-0822 · Cited by 80
Self-citationMcNerney, K. O., DiNofia, A. M., Teachey, D. T., Grupp, S. A., & Maude, S. L. (2021) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-21-0203 · Cited by 73
Self-citationMiller, K. C., Johnson, P. C., Abramson, J. S., Soumerai, J. D., Yee, A. J., Branagan, A. R., O’Donnell, E., Saucier, A., Jacobson, C. A., Frigault, M. J., et al. (2022) · Blood Cancer Journal · doi:10.1038/s41408-022-00741-2 · Cited by 72
Self-citationG-CSF does not worsen toxicities and efficacy of CAR-T cells in refractory/relapsed B-cell lymphoma
Galli, E., Allain, V., Blasi, R. D., Bernard, S., Vercellino, L., Morin, F., Moatti, H., Caillat‐Zucman, S., Chevret, S., & Thiéblemont, C. (2020) · Bone Marrow Transplantation · doi:10.1038/s41409-020-01006-x · Cited by 71
Rejeski, K., Burchert, A., Iacoboni, G., Sesques, P., Fransecky, L. R., Bücklein, V., Trenker, C., Hernani, R., Naumann, R., Schäfer, J., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007776 · Cited by 69
Buechner, J., Grupp, S. A., Hiramatsu, H., Teachey, D. T., Rives, S., Laetsch, T. W., Yanik, G. A., Wood, P. A., Awasthi, R., Yi, L., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002757 · Cited by 66
Self-citationCanna, S., & Behrens, E. M. (2011) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32834dd37e · Cited by 63
Intravenous administration of anakinra in children with macrophage activation syndrome
Phadke, O., Rouster‐Stevens, K. A., Giannopoulos, H. T., Chandrakasan, S., & Prahalad, S. (2021) · Pediatric Rheumatology · doi:10.1186/s12969-021-00585-3 · Cited by 63
How i treat primary haemophagocytic lymphohistiocytosis
Marsh, R. A., & Haddad, É. (2018) · British Journal of Haematology · doi:10.1111/bjh.15274 · Cited by 61
Self-citationWang, J., Zhang, R., Wu, X., Li, F., Yang, H., Liu, L., Guo, H., Zhang, X., Mai, H., Li, H., et al. (2021) · British Journal of Haematology · doi:10.1111/bjh.17331 · Cited by 60
Anakinra utilization in refractory pediatric CAR T-cell associated toxicities
Diorio, C. J., Vatsayan, A., Talleur, A. C., Annesley, C., Jaroscak, J., Shalabi, H., Ombrello, A. K., Hudspeth, M. P., Maude, S. L., Gardner, R. A., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022006983 · Cited by 60
Self-citationKennedy, V. E., Wong, C., Huang, C., Kambhampati, S., Wolf, J. L., Martin, T. G., Shah, N. D., & Wong, S. W. K. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005020 · Cited by 58
Self-citationHorne, A., Greenwood, T. V. B., Chiang, S. C. C., Meeths, M., Björklund, C., Ekelund, M., Erensjö, P., Berg, S., Hagelberg, S., Bryceson, Y. T., et al. (2021) · The Journal of Rheumatology · doi:10.3899/jrheum.200941 · Cited by 58
Self-citationDadwal, S., Hohl, T. M., Fisher, C. E., Boeckh, M., Papanicolaou, G., Carpenter, P. A., Fisher, B. T., Slavin, M. A., & Kontoyiannis, D. P. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2020.10.003 · Cited by 57
Hemophagocytic lymphohistiocytosis in children with chronic granulomatous disease
Parekh, C., Hofstra, T. C., Church, J. A., & Coates, T. D. (2010) · Pediatric Blood & Cancer · doi:10.1002/pbc.22830 · Cited by 56
Hashmi, H., Bachmeier, C. A., Chávez, J. C., Song, J., Hussaini, M., Krivenko, G. S., Nishihori, T., Kotani, H., Davila, M. L., Locke, F. L., et al. (2019) · British Journal of Haematology · doi:10.1111/bjh.16155 · Cited by 55
Self-citationMaruoka, H., Inoue, D., Takiuchi, Y., Nagano, S., Arima, H., Tabata, S., Matsushita, A., Ishikawa, T., Oita, T., & Takahashi, T. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1878-y · Cited by 53
Song, Y., Wang, Y., & Wang, Z. (2019) · British Journal of Haematology · doi:10.1111/bjh.15988 · Cited by 50
Major, A., Collins, J., Craney, C., Heitman, A. K., Bauer, E., Zerante, E., Stock, W., Bishop, M. R., & Jasielec, J. K. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1881507 · Cited by 50
Martín‐Rojas, R. M., Gómez-Centurión, I. A., Bailén, R., Bastos‐Oreiro, M., Diaz-Crespo, F. J., Carbonell, D., Correa‐Rocha, R., Pion, M., Muñoz, C., Sancho, M., et al. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5209 · Cited by 49
CD34+-selected stem cell boost can safely improve cytopenias following CAR T-cell therapy
Mullanfiroze, K., Lazareva, A., Chu, J., Williams, L., Burridge, S., Silva, J., Chiesa, R., Rao, K., Lucchini, G., Ghorashian, S., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007572 · Cited by 49
Zurko, J. C., Johnson, B. D., Aschenbrenner, E., Fenske, T. S., Hamadani, M., Hari, P., & Shah, N. N. (2022) · JAMA Oncology · doi:10.1001/jamaoncol.2022.0070 · Cited by 45
Self-citationHyperinflammation: On the pathogenesis and treatment of macrophage activation syndrome
Andersson, J. (2021) · Acta Paediatrica · doi:10.1111/apa.15900 · Cited by 44
Hemophagocytosis exacerbated by G‐CSF/GM‐CSF treatment in a patient with myelodysplasia
Wang, S., Degar, B. A., Zieske, A. W., Shafi, N. Q., & Rose, M. G. (2004) · American Journal of Hematology · doi:10.1002/ajh.20202 · Cited by 43
Alemtuzumab as First Line Treatment in Children with Familial Lymphohistiocytosis
Moshous, D., Briand, C., Castelle, M., Dupic, L., Morelle, G., Chahla, W. A., Barlogis, V., Bertrand, Y., Bruno, B., Jeziorski, É., et al. (2019) · Blood · doi:10.1182/blood-2019-124477 · Cited by 35
Outcomes Analysis of Children Diagnosed With Hemophagocytic Lymphohistiocytosis in the PICU
Gregory, J. L., Greenberg, J., & Basu, S. (2018) · Pediatric Critical Care Medicine · doi:10.1097/pcc.0000000000001827 · Cited by 32
Marón, G. M., Hijano, D. R., Epperly, R., Su, Y., Tang, L., Hayden, R. T., Naik, S., Karol, S. E., Gottschalk, S. M., Triplett, B. M., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.845540 · Cited by 31
Self-citationSong, Y., Wang, J., Wang, Y., Wu, L., & Wang, Z. (2021) · Cancer Biology & Therapy · doi:10.1080/15384047.2021.1996139 · Cited by 27
Kim, J. Y., Kim, M., Park, J. K., Lee, E. B., Park, J. W., & Hong, J. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02516-1 · Cited by 27
Charlesworth, J. E. G., Wilson, S. R., Qureshi, A., Blanco, E., Mitchell, A. F., Segal, S., Kelly, D. F., Weitz, J., O'Shea, D., Bailey, K. M., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29102 · Cited by 22
Palmblad, K., Schierbeck, H., Sundberg, E., Horne, A., Harris, H. E., Henter, J., & Andersson, J. (2021) · Molecular Medicine · doi:10.1186/s10020-021-00308-0 · Cited by 17
Self-citationMasih, K. E., Ligon, J. A., Yates, B., Shalabi, H., Little, L., Islam, Z., Ombrello, A. K., Inglefield, J. R., Nussenblatt, V. R., Manion, M. M., et al. (2021) · Pediatric Blood & Cancer · doi:10.1002/pbc.29247 · Cited by 17
Self-citationIntravenous anakinra for tisagenlecleucel-related toxicities in children and young adults
Dreyzin, A., Jacobsohn, D. A., Angiolillo, A. L., Wistinghausen, B., Schore, R. J., Perez‐Albuerne, E. D., Wells, E. M., Terao, J., Bonifant, C. L., Rohatgi, R., et al. (2021) · Pediatric Hematology and Oncology · doi:10.1080/08880018.2021.1988012 · Cited by 13
Self-citationPéterlin, P., Garnier, A., Bourgeois, A. L., Jullien, M., Seguin, A., Eveillard, M., Béné, M. C., Guillaume, T., & Chevallier, P. (2022) · Acta Haematologica · doi:10.1159/000525576 · Cited by 12
HLH treatment: smarter, not harder
Henderson, L. A., & Degar, B. A. (2022) · Blood · doi:10.1182/blood.2022016421 · Cited by 11
Silva, P. R. D. O., Bailén, R., Oarbeascoa, G., Gómez-Centurión, I. A., Pérez‐Corral, A. M., Carbonell, D., Martínez‐Laperche, C., Sancho, M., Bastos‐Oreiro, M., Conde-Royo, D., et al. (2022) · Transfusion · doi:10.1111/trf.17071 · Cited by 9
Cited by
Rejeski, K., Subklewe, M., Aljurf, M., Bachy, E., Balduzzi, A., Barba, P., Bruno, B., Benjamin, R., Carrabba, M. G., Chabannon, C., et al. (2023) · Blood · doi:10.1182/blood.2023020578 · Cited by 358
In vivo CAR T cell generation to treat cancer and autoimmune disease
Hunter, T. L., Bao, Y., Zhang, Y., Matsuda, D., Riener, R., Wang, A., Li, J. J., Soldevila, F., Chu, D. S. H., Nguyen, D. P., et al. (2025) · Science · doi:10.1126/science.ads8473 · Cited by 330
Current understanding and management of CAR T cell-associated toxicities
Brudno, J. N., & Kochenderfer, J. N. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00903-0 · Cited by 305
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
Cordas dos Santos, D. M., Tix, T., Shouval, R., Gafter-Gvili, A., Alberge, J.-B., Cliff, E. R. S., Theurich, S., von Bergwelt-Baildon, M., Ghobrial, I. M., Subklewe, M., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03084-6 · Cited by 287
Self-citation
Metadata
- Authors
- Hines, M. R., Knight, T. E., McNerney, K. O., Leick, M. B., Jain, T., Ahmed, S., Frigault, M. J., Hill, J. A., Jain, M. D., Johnson, W. T., Lin, Y., Mahadeo, K. M., Maron, G. M., Marsh, R. A., Neelapu, S. S., Nikiforow, S., Ombrello, A. K., Shah, N. N., Talleur, A. C., Turicek, D., Vatsayan, A., Wong, S. W., Maus, M. V., Komanduri, K. V., Berliner, N., Henter, J.-I., Perales, M.-A., Frey, N. V., Teachey, D. T., Frank, M. J., & Shah, N. N.
- Venue
- Transplantation and Cellular Therapy
- Publisher
- Elsevier BV
- Published
- 2023-07
- Volume
- 29
- Issue
- 7
- Pages
- 438.e1-438.e16
- ISSN
- 1083-8791 (ISSN-L)
- 2666-6367
- OpenAlex
- W4323659812
- Cited by
- 338
- References
- 126
- FWCI
- 60.23
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.